Cached score snapshot

US.EW · Edwards Lifesciences

110分制 62.6/110;5D動能v2 9/50;排序分 71.6/160

Ranking score 71.6/160
Main score 62.6/110
5D momentum v2 9/50
Rank #118
Setup grade D 38.5

Score breakdown

觀望

Medium twelvedata

Score and price trend

D 38.5 Money flow A · Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 04-10 07-14 07-27 08-06 08-18 $73.75$93.59$113.43 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 3.07 · anchors 120 +0.38% -1.59% / +2.73% 55% 2% Actual -2.75% · vs median -3.13% · inside 25-75 band
30D observation +4.81% -1.94% / +10.52% 69% 18% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 -0.23% -2.15% / +2.88% 46.3% 2.5% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-04-10 → 2026-08-18 · 438 archived points · 2 Improving turn signal · 7 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 71.6
Display grade 觀望
Model version cursor_18_27_news_v2_160
Main score 62.6/110 (觀望)
5D momentum v2 9/50 (弱)
Score with momentum v2 71.6/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 89.0065
ma50 85.802
close 94.82
prevClose 95.18
avgVolume20 4762457
volumeRatio 0.93
changePercent -0.38

Metrics snapshot

close 94.82
volume 4420330
changePercent -0.38

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 62.6/110
Main rating 觀望
5D momentum v2 9/50
Score with momentum v2 71.6/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.1/5 · 一般

Dimension score 3.1/5
Dimension grade 一般

Sub-items

pbPoints 0.2
pePoints 0.2
epsPoints 0
roePoints 0.4
debtPoints 0.5
marginPoints 0.4
turnoverUsdM 419.1357
volumePoints 0.5
revenuePoints 0.4
dividendPoints 0
marketCapPoints 0.5

資金流 — 14.8/20 · 良好

Dimension score 14.8/20
Dimension grade 良好

Sub-items

cmfPoints 0.8
mfiPoints 4
obvPoints 4
vwapPoints 4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.EW
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 8.6/15 · 較差

Dimension score 8.6/15
Dimension grade 較差

Sub-items

vix

score 2.4

details

source twelvedata+fred
vixClose 15.57

trend

score 2.4

details

qqq

ma20 720.433
ma50 711.664
name QQQ
close 709.43
points 0.4

spy

ma20 741.2935
ma50 739.0122
name SPY
close 747.71
points 2
source twelvedata+fred
atrPct 2.6072
atrPoints 3
cciPoints 0.8
vixPoints 2.4
marketTrendPoints 2.4

催化劑 — 2/20 · 較差

Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 2
catalystCount 0
catalystPoints 2

風險管理 — 6.8/10 · 一般

Dimension score 6.8/10
Dimension grade 一般

Sub-items

position

score 1.6

details

atrPct 2.6072
turnoverUsdM 419.1357
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.EW
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 89.8758

strength_details

ma_score 1.5
atr_score 2
rsi_score 0.5
macd_score 3
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 5.2
take_profit_price 99.9867
target_multiplier 1.9
technical_strength 1.65
take_profit_percent 5.4
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.2143
diversificationPoints 2

技術信號 — 21.3/30 · 良好

Dimension score 21.3/30
Dimension grade 良好

Sub-items

bbPoints 3
adxPoints 3
sarPoints 2.4
vcpPoints 1.6
macdPoints 4

vcpPayload

vcp_pass false
vcp_score 1.6
vcp_reason 波幅收縮(14.5%→10.8%);站上MA50;Ready=N;Confirm=N

vcp_metrics

up_days 8
vol_ref 5158956.6667
down_days 1
vcp_ready false
above_ma50 true
avg_vol_10 4966750
avg_vol_20 4830390
avg_vol_30 5158956.6667
range_pct_10 0.1081
range_pct_20 0.1308
range_pct_30 0.145
up_expand_ok false
lookback_used 59
near_20d_high true
contraction_ok true
down_shrink_ok false
up_expand_days 1
breakout_20d_ok false
vol_ratio_10_30 0.9627
dist_to_20d_high 0.0078
down_shrink_days 1
breakout_level_20d 95.57
vcp_breakout_confirm false
contraction_ratio_10_30 0.7455
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction true
kdjAdxPoints 0.7
rsiKdjPoints 2.4
volumeWeight 2
maCrossPoints 1.6
shortRsiPoints 0.8
shortMacdPoints 0.4
volConfirmPoints 0.6
volumePointsTechnical 0.8

情緒分析 — 6/10 · 一般

Dimension score 6/10
Dimension grade 一般

Sub-items

sentiment

score 6

details

source finnhub_news_keyword_model
articleCount 2
negativeHits 0
positiveHits 1
sentimentScoreRaw 1.2

sentimentData

raw {"id":140768835,"url":"https://finnhub.io/api/news?id=36383ca999e0e2d8c2c95f816b33e0074c375d4162675966285778927441e0f4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"EW","summary":"In late June 2026, Edwards Lifesciences presented extensive new clinical data at the New York Valves conference, reinforcing evidence across its aortic, mitral and tricuspid transcatheter valve therapies, including PROGRESS, PARTNER 3, EARLY TAVR, PASCAL and SAPIEN M3 programs. An important takeaway is how the PROGRESS trial’s baseline data on moderate aortic stenosis and long-term durability findings for SAPIEN 3 deepen understanding of earlier, less invasive treatment options for complex...","category":"company","datetime":1782778531,"headline":"Edwards Lifesciences (EW) Is Up 6.2% After New TAVR Data at New York Valves Conference"}, {"id":140617502,"url":"https://finnhub.io/api/news?id=3440504532b35800b440041e745c94590c02c83e57a3e183f93b4024ede5ed35","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"EW","summary":"Edwards gains from strong TMTT growth, RESILIA adoption and expanding TAVR use, but macro pressures and currency swings remain key risks.","category":"company","datetime":1781267460,"headline":"Should You Continue to Hold EW Stock in Your Portfolio?"}
raw_source {"id":140825083,"url":"https://finnhub.io/api/news?id=d4831a06a8b6f7f3feb8ad73f380bfa82b004b8eec49a45e787a5b8408bd3d1d","image":"","source":"Benzinga","related":"EW","summary":"Evercore ISI Group analyst Vijay Kumar maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $93 to $100.","category":"company","datetime":1783339812,"headline":"Evercore ISI Group Maintains Outperform on Edwards Lifesciences, Raises Price Target to $100"}, {"id":140785971,"url":"https://finnhub.io/api/news?id=9417d92376a940320b0658b48d238996e548963863d2897c4d2a6cdaa04c2ccb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"EW","summary":"Edwards Lifesciences is scheduled to report its second-quarter results soon, and analysts expect a single-digit earnings rise.","category":"company","datetime":1782923534,"headline":"What You Need To Know Ahead of Edwards Lifesciences' Earnings Release"}, {"id":140772402,"url":"https://finnhub.io/api/news?id=29928c6dad2caaf8f5b48d7ed19e8c0bf20103ebebf8dcb587da59e9c1cee1d6","image":"https://cdn.benzinga.com/files/images/story/2026/06/30/Orlando--Fl--Usa---January-20--2022-Dard.jpg?width=2048&height=1536","source":"Benzinga","related":"EW","summary":"Wall Street analysts changed outlook on top names. Wedbush raised Replimune's price target, Canaccord cut Strategy's target, Barclays upgraded Watts Water, Rosenblatt boosted Comcast, Goldman increased State Street, Evercore raised Owens Corning, Cantor Fitzgerald boosted BioCryst Pharma, BTIG raised Edwards Lifesciences.","category":"company","datetime":1782810296,"headline":"Darden Restaurants To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday"}, {"id":140774055,"url":"https://finnhub.io/api/news?id=67d042810efc8c2c01c9cd0720b35451092be688f1c6d77f410c83941db8fe06","image":"","source":"Benzinga","related":"EW","summary":"BTIG analyst Marie Thibault maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $100 to $110.","category":"company","datetime":1782806186,"headline":"BTIG Maintains Buy on Edwards Lifesciences, Raises Price Target to $110"}, {"id":140768835,"url":"https://finnhub.io/api/news?id=36383ca999e0e2d8c2c95f816b33e0074c375d4162675966285778927441e0f4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"EW","summary":"In late June 2026, Edwards Lifesciences presented extensive new clinical data at the New York Valves conference, reinforcing evidence across its aortic, mitral and tricuspid transcatheter valve therapies, including PROGRESS, PARTNER 3, EARLY TAVR, PASCAL and SAPIEN M3 programs. An important takeaway is how the PROGRESS trial’s baseline data on moderate aortic stenosis and long-term durability findings for SAPIEN 3 deepen understanding of earlier, less invasive treatment options for complex...","category":"company","datetime":1782778531,"headline":"Edwards Lifesciences (EW) Is Up 6.2% After New TAVR Data at New York Valves Conference"}, {"id":140765508,"url":"https://finnhub.io/api/news?id=114499e6dd4eaa6ca7fb68293857493880ef5d632bdbecc410078617b2bb4682","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"EW","summary":"Intuitive Surgical's Quintuple Aim strategy is driving premium pricing as da Vinci 5 adoption grows, with innovation-led revenue growth outpacing procedure growth.","category":"company","datetime":1782754560,"headline":"Can ISRG's 'Quintuple Aim' Strategy Continue to Justify Premium Pricing?"}, {"id":140764119,"url":"https://finnhub.io/api/news?id=2558ab0870b5c4bd52b22a6d7cbb6ec5c9eb3d3645adb5a45d03774f7d39dc10","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"EW","summary":"Edwards Lifesciences (EW) can sustain a high revenue growth rate given its technological leadership","category":"company","datetime":1782750579,"headline":"Edwards Lifesciences Can Sustain Strong Revenue Growth on Technological Leadership, RBC Says"}, {"id":140764120,"url":"https://finnhub.io/api/news?id=15115c8ddf386bc50ddc3fb9d01795b6c1cbd80a889b327a585df6d4ea69da48","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"EW","summary":"Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, targeted rollout,” one analyst said.","category":"company","datetime":1782731798,"headline":"Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic"}, {"id":140736627,"url":"https://finnhub.io/api/news?id=617247ab6b79fad40362b749ec64c44ac950f3493e24f2fb8d960847fa1cdeb8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"EW","summary":"NEW YORK, June 26, 2026--Edwards Lifesciences (NYSE: EW) today announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which reinforce the company's leadership in advancing high-quality scientific evidence and innovating for patients. These new data – spanning aortic, mitral and tricuspid therapies – provide further understanding of the complexity of structural heart disease and the need for innovative treatment options.","category":"company","datetime":1782483300,"headline":"Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves"}, {"id":140712255,"url":"https://finnhub.io/api/news?id=a9a0f050cff8fd433fe6026943b71c8fdff53264da5ddef0fa11d04499e6f753","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"EW","summary":"Norway-based CardioMech AS, a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology in Fridley, MN, today announced the appointment of Ramin Mousavi as Chairman of the Board, effective immediately.","category":"company","datetime":1782295260,"headline":"CardioMech Shareholders Appoint Ramin Mousavi as Chairman of the Board"}, {"id":140692686,"url":"https://finnhub.io/api/news?id=9136e702e7dfcc5d1df79a35985827ce407a733b50c7ff47e028abad22e65c19","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"EW","summary":"Globus Medical faces inflation, geopolitical and currency pressures as rising costs and FX losses cloud margin flexibility and international growth.","category":"company","datetime":1782138480,"headline":"Here's How Macro Trends and Currency Headwind Restrict GMED's Growth"}, {"id":140691146,"url":"https://finnhub.io/api/news?id=843562ed61fee58039a285e36f019315c1d1a32065cd26057a37a4840411af50","image":"https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp","source":"ChartMill","related":"EW","summary":"Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.","category":"company","datetime":1782131700,"headline":"What's going on in today's pre-market session: S&P500 movers"}, {"id":140649984,"url":"https://finnhub.io/api/news?id=4d3531c17ab01cc674c5d093405b9301938682be5e2f3d2c05b0282b3d78a4fe","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"EW","summary":"The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.57%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.89%. June E-mini S&P futures (ESM26 ) fell -0.60%, and June E-mini Nasdaq futures...","category":"company","datetime":1781642036,"headline":"Stocks Indexes Finish Mostly Lower as Chipmakers Retreat"}, {"id":140646075,"url":"https://finnhub.io/api/news?id=21e901af7de0ec0c8d3fab3785c00c1c5e94d83a5ea7dcac3909c404c4549df4","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"EW","summary":"Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.","category":"company","datetime":1781627701,"headline":"Exploring the top movers within the S&P500 index during today's session."}, {"id":140645723,"url":"https://finnhub.io/api/news?id=079359cd4836c6e3619ed467a2a41e63411fc713f6730aadcbd94434c4558687","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"EW","summary":"Edwards Lifesciences (EW) is expected to benefit from the Centers for Medicare & Medicaid Services'","category":"company","datetime":1781624993,"headline":"Edwards Lifesciences Seen Benefiting From CMS Transcatheter Aortic Valve Replacement Rule, RBC Says"}, {"id":140649043,"url":"https://finnhub.io/api/news?id=ed3cde22831ae1098d949d7d33b72dd9da82db5fee1fc510faa8b2594a4fd5de","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"EW","summary":"The S&P 500 Index ($SPX ) (SPY ) today is down -0.18%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.69%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.83%. June E-mini S&P futures (ESM26 ) are down -0.20%, and June E-mini Nasdaq futures...","category":"company","datetime":1781622938,"headline":"Broader Market Weakens as Energy and Software Stocks Fall"}, {"id":140648875,"url":"https://finnhub.io/api/news?id=638b4a14e4a9725ebf97bb9f2652aa7a734159b63f87d2a7f2d27b885c9ab349","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"EW","summary":"The S&P 500 Index ($SPX ) (SPY ) today is up +0.11%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.57%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.18%. June E-mini S&P futures (ESM26 ) are up +0.09%, and June E-mini Nasdaq futures...","category":"company","datetime":1781619490,"headline":"Stocks Supported by Lower Crude Oil Prices and Bond Yields"}, {"id":140657685,"url":"https://finnhub.io/api/news?id=fa7001622e453f3c8a87f2cfb80ca9ccd62c8ad4efd0d5b139f0eda1c28b0a96","image":"https://cdn.benzinga.com/files/images/story/2026/06/16/Irvine--California---7-May-2023-Edwards-.jpeg?width=2048&height=1536","source":"Benzinga","related":"EW","summary":"CMS proposes easing TAVR coverage rules and expanding access, a move analysts say could strengthen Edwards Lifesciences' market position.","category":"company","datetime":1781617967,"headline":"Edwards Lifesciences Stands Out As US Agency Eyes Broader Access For Heart Valve Device"}, {"id":140654422,"url":"https://finnhub.io/api/news?id=4310716eabd489977375bda6235de8bf999adc394f0dcb834a28574bbda42de0","image":"https://image.cnbcfm.com/api/v1/image/108322628-17816273621781627357-46583759523-1080pnbcnews.jpg?v=1781627361&w=1920&h=1080","source":"CNBC","related":"EW","summary":"The Investment Committee debate how to position your portfolio near record highs as stocks look to extend the Monday snapback.","category":"company","datetime":1781614266,"headline":"The market rally's road ahead: How to position near record highs"}, {"id":140644822,"url":"https://finnhub.io/api/news?id=b8ebd9a3b34af8095ea3d9e0bdd2ecb876408be3cd6107aefe82da74b3240ec6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"EW","summary":"Investing.com - U.S. stock futures were little changed on Tuesday, while oil prices extended recent losses, as investors awaited further details on a preliminary peace agreement between the United States and Iran.","category":"company","datetime":1781613852,"headline":"SpaceX, Rackspace surge premarket; Edgewise Therapeutics, Huntsman fall"}, {"id":140644730,"url":"https://finnhub.io/api/news?id=856f656f82ba08e49ec9bf8abb135b4efc9a69ec0d62382256c4dd6e45725cdb","image":"https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp","source":"ChartMill","related":"EW","summary":"Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session.","category":"company","datetime":1781613300,"headline":"Stay updated with the S&P500 stocks that are on the move in today's pre-market session."}, {"id":140647034,"url":"https://finnhub.io/api/news?id=3d96b5ea169e397d4b4305ec49ea961dfeead658b7d81538363b53ec5e3584b7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"EW","summary":"The proposed Medicare coverage change could help Edwards Lifesciences gain market share from Medtronic and Boston Scientific, an analyst said.","category":"company","datetime":1781607916,"headline":"CMS proposes Medicare coverage expansion for TAVR"}, {"id":140645988,"url":"https://finnhub.io/api/news?id=c42054ddc0086ea279f32492940ebd700e57bc00d6b6d7ebb49c91219990ae2c","image":"","source":"Benzinga","related":"EW","summary":"RBC Capital analyst Shagun Singh reiterates Edwards Lifesciences (NYSE:EW) with a Outperform and maintains $100 price target.","category":"company","datetime":1781602507,"headline":"RBC Capital Reiterates Outperform on Edwards Lifesciences, Maintains $100 Price Target"}, {"id":140617502,"url":"https://finnhub.io/api/news?id=3440504532b35800b440041e745c94590c02c83e57a3e183f93b4024ede5ed35","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"EW","summary":"Edwards gains from strong TMTT growth, RESILIA adoption and expanding TAVR use, but macro pressures and currency swings remain key risks.","category":"company","datetime":1781267460,"headline":"Should You Continue to Hold EW Stock in Your Portfolio?"}, {"id":140582299,"url":"https://finnhub.io/api/news?id=fb6f13d08b877506eee8ba1556c9c2305e7b73adbdfdf44d203c6b6b2cbdd90b","image":"https://image.cnbcfm.com/api/v1/image/108318920-17810228181781022815-46442812417-1080pnbcnews.jpg?v=1781022817&w=1920&h=1080","source":"CNBC","related":"EW","summary":"The Investment Committee debate the latest Calls of the Day.","category":"company","datetime":1781008925,"headline":"Calls of the Day: Health Care and Materials"}
data_source finnhub_news_keyword_model
article_count 2
negative_hits 0
positive_hits 1
recomputed_at_score true
sentiment_score_raw 1.2
source_article_count 25
discarded_article_count 23
sentimentPoints 6

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.1 5/110 62% 3.1
資金流 14.8 20/110 74% 14.8
市場環境 8.6 15/110 57.33% 8.6
催化劑 2 20/110 10% 2
風險管理 6.8 10/110 68% 6.8
技術信號 21.3 30/110 71% 21.3
情緒分析 6 10/110 60% 6

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 9/50
ret_5d 0.0399
max_score 50
max_total 50
raw_total 9
vcp_bonus 0
vol_ratio 0.9151
ret_points 8
vol_points 0
range_ratio 0.8058
volat_points 0
day_range_pct 0.022
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 1
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 2.6072
turnoverUsdM 419.1357
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.EW
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 89.8758

strength_details

ma_score 1.5
atr_score 2
rsi_score 0.5
macd_score 3
volume_score 1
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 5.2
take_profit_price 99.9867
target_multiplier 1.9
technical_strength 1.65
take_profit_percent 5.4
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.2143
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.1/5分
資金流分析總分: 14.8/20分
市場環境分析總分: 8.6/15分
催化劑分析: 2/20分
風險管理總分: 6.8/10分
技術信號分析總分: 21.3/30分
情緒分析: 6/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 85.71
atr
atr 2.4721
rule ATR / current price; lower volatility scores higher
score 6
atr_pct 2.61
cci
rule Cursor_18.24 CCI bands
level 超買或超賣風險
score 2
value 152.42
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.0005
kdj
d 82.4
j 96.13
k 86.98
rule Cursor_18.24 K/D cross
score 4
signal 金叉
mfi
rule Cursor_18.24 MFI bands
level 強資金流入
score 10
value 75.48
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 10
trend 強流入
value 59506370
recentSlope 3025847
previousSlope -94420
rsi
value 74.46
sar
rule Cursor_18.24 Parabolic SAR
score 8
trend 上升
value 87.9818
position SAR喺價下
distancePct 7.21
previousTrend 上升
ma50
value 85.802
macd
macd 2.448
trend 強烈看漲
signal 1.8522
histogram 0.5959
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 10
value 89.07
position 連續5日>VWAP
consecutiveAbove 10
volume
rule Cursor_18.24 volume ratio
level 無力
ratio 0.93
score 4
avgVolume 4762457
currentVolume 4420330
derived
ma20 89.0065
ma50 85.802
prevClose 95.18
avgVolume10 5058133
avgVolume20 4762457
changePercent -0.38
avgVolumeForScore 4762457
ma_cross
ma20 89.0065
ma50 85.802
rule Cursor_18.24 MA20/MA50 cross
cross 多頭
score 4
prevMa20 88.5635
prevMa50 85.5
spreadPct 3.73
isVolumeBreakout false
bollinger
lower 82.7258
upper 95.2872
position 上半部
rsi_short
value 82.58
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 0.93

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.6071503902130355,
        "turnoverUsdM": 419.1356906,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.EW",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 89.8758,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 5.2,
      "take_profit_price": 99.9867,
      "target_multiplier": 1.9,
      "technical_strength": 1.65,
      "take_profit_percent": 5.4
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.214300780426071,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 71.6,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 62.6,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 9
  },
  "market": {
    "ma20": 89.0065,
    "ma50": 85.802,
    "close": 94.82,
    "prevClose": 95.18,
    "avgVolume20": 4762457,
    "volumeRatio": 0.93,
    "changePercent": -0.38
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 9,
    "details": {
      "ret_5d": 0.03992103531476188,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 9,
      "vcp_bonus": 0,
      "vol_ratio": 0.9151083038843655,
      "ret_points": 8,
      "vol_points": 0,
      "range_ratio": 0.8057943464497517,
      "volat_points": 0,
      "day_range_pct": 0.022041763341067323,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 71.6,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.1,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 62,
        "contribution": 3.1
      },
      {
        "raw": 14.8,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 74,
        "contribution": 14.8
      },
      {
        "raw": 8.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 57.33,
        "contribution": 8.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.8,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 68,
        "contribution": 6.8
      },
      {
        "raw": 21.3,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 71,
        "contribution": 21.3
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 62.6,
    "details": [
      "基本面分析總分: 3.1/5分",
      "資金流分析總分: 14.8/20分",
      "市場環境分析總分: 8.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.8/10分",
      "技術信號分析總分: 21.3/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.1,
      "資金流": 14.8,
      "市場環境": 8.6,
      "情緒分析": 6,
      "技術信號": 21.3,
      "風險管理": 6.8
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 2,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.4,
          "debtPoints": 0.5,
          "marginPoints": 0.4,
          "turnoverUsdM": 419.1356906,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "良好",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 4,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.EW",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.57
            }
          },
          "trend": {
            "score": 2.4,
            "details": {
              "qqq": {
                "ma20": 720.4330052000001,
                "ma50": 711.66400144,
                "name": "QQQ",
                "close": 709.42999,
                "points": 0.4
              },
              "spy": {
                "ma20": 741.2935059,
                "ma50": 739.0122021000002,
                "name": "SPY",
                "close": 747.71002,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.6071503902130355,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 2.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 2,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 1.2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140768835,
                "url": "https://finnhub.io/api/news?id=36383ca999e0e2d8c2c95f816b33e0074c375d4162675966285778927441e0f4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "In late June 2026, Edwards Lifesciences presented extensive new clinical data at the New York Valves conference, reinforcing evidence across its aortic, mitral and tricuspid transcatheter valve therapies, including PROGRESS, PARTNER 3, EARLY TAVR, PASCAL and SAPIEN M3 programs. An important takeaway is how the PROGRESS trial’s baseline data on moderate aortic stenosis and long-term durability findings for SAPIEN 3 deepen understanding of earlier, less invasive treatment options for complex...",
                "category": "company",
                "datetime": 1782778531,
                "headline": "Edwards Lifesciences (EW) Is Up 6.2% After New TAVR Data at New York Valves Conference"
              },
              {
                "id": 140617502,
                "url": "https://finnhub.io/api/news?id=3440504532b35800b440041e745c94590c02c83e57a3e183f93b4024ede5ed35",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards gains from strong TMTT growth, RESILIA adoption and expanding TAVR use, but macro pressures and currency swings remain key risks.",
                "category": "company",
                "datetime": 1781267460,
                "headline": "Should You Continue to Hold EW Stock in Your Portfolio?"
              }
            ],
            "raw_source": [
              {
                "id": 140825083,
                "url": "https://finnhub.io/api/news?id=d4831a06a8b6f7f3feb8ad73f380bfa82b004b8eec49a45e787a5b8408bd3d1d",
                "image": "",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Evercore ISI Group  analyst Vijay Kumar   maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $93 to $100.",
                "category": "company",
                "datetime": 1783339812,
                "headline": "Evercore ISI Group Maintains Outperform on Edwards Lifesciences, Raises Price Target to $100"
              },
              {
                "id": 140785971,
                "url": "https://finnhub.io/api/news?id=9417d92376a940320b0658b48d238996e548963863d2897c4d2a6cdaa04c2ccb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences is scheduled to report its second-quarter results soon, and analysts expect a single-digit earnings rise.",
                "category": "company",
                "datetime": 1782923534,
                "headline": "What You Need To Know Ahead of Edwards Lifesciences' Earnings Release"
              },
              {
                "id": 140772402,
                "url": "https://finnhub.io/api/news?id=29928c6dad2caaf8f5b48d7ed19e8c0bf20103ebebf8dcb587da59e9c1cee1d6",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/30/Orlando--Fl--Usa---January-20--2022-Dard.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Wall Street analysts changed outlook on top names. Wedbush raised Replimune's price target, Canaccord cut Strategy's target, Barclays upgraded Watts Water, Rosenblatt boosted Comcast, Goldman increased State Street, Evercore raised Owens Corning, Cantor Fitzgerald boosted BioCryst Pharma, BTIG raised Edwards Lifesciences.",
                "category": "company",
                "datetime": 1782810296,
                "headline": "Darden Restaurants To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Tuesday"
              },
              {
                "id": 140774055,
                "url": "https://finnhub.io/api/news?id=67d042810efc8c2c01c9cd0720b35451092be688f1c6d77f410c83941db8fe06",
                "image": "",
                "source": "Benzinga",
                "related": "EW",
                "summary": "BTIG  analyst Marie Thibault   maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $100 to $110.",
                "category": "company",
                "datetime": 1782806186,
                "headline": "BTIG Maintains Buy on Edwards Lifesciences, Raises Price Target to $110"
              },
              {
                "id": 140768835,
                "url": "https://finnhub.io/api/news?id=36383ca999e0e2d8c2c95f816b33e0074c375d4162675966285778927441e0f4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "In late June 2026, Edwards Lifesciences presented extensive new clinical data at the New York Valves conference, reinforcing evidence across its aortic, mitral and tricuspid transcatheter valve therapies, including PROGRESS, PARTNER 3, EARLY TAVR, PASCAL and SAPIEN M3 programs. An important takeaway is how the PROGRESS trial’s baseline data on moderate aortic stenosis and long-term durability findings for SAPIEN 3 deepen understanding of earlier, less invasive treatment options for complex...",
                "category": "company",
                "datetime": 1782778531,
                "headline": "Edwards Lifesciences (EW) Is Up 6.2% After New TAVR Data at New York Valves Conference"
              },
              {
                "id": 140765508,
                "url": "https://finnhub.io/api/news?id=114499e6dd4eaa6ca7fb68293857493880ef5d632bdbecc410078617b2bb4682",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Intuitive Surgical's Quintuple Aim strategy is driving premium pricing as da Vinci 5 adoption grows, with innovation-led revenue growth outpacing procedure growth.",
                "category": "company",
                "datetime": 1782754560,
                "headline": "Can ISRG's 'Quintuple Aim' Strategy Continue to Justify Premium Pricing?"
              },
              {
                "id": 140764119,
                "url": "https://finnhub.io/api/news?id=2558ab0870b5c4bd52b22a6d7cbb6ec5c9eb3d3645adb5a45d03774f7d39dc10",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences (EW) can sustain a high revenue growth rate given its technological leadership",
                "category": "company",
                "datetime": 1782750579,
                "headline": "Edwards Lifesciences Can Sustain Strong Revenue Growth on Technological Leadership, RBC Says"
              },
              {
                "id": 140764120,
                "url": "https://finnhub.io/api/news?id=15115c8ddf386bc50ddc3fb9d01795b6c1cbd80a889b327a585df6d4ea69da48",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, targeted rollout,” one analyst said.",
                "category": "company",
                "datetime": 1782731798,
                "headline": "Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic"
              },
              {
                "id": 140736627,
                "url": "https://finnhub.io/api/news?id=617247ab6b79fad40362b749ec64c44ac950f3493e24f2fb8d960847fa1cdeb8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "NEW YORK, June 26, 2026--Edwards Lifesciences (NYSE: EW) today announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which reinforce the company's leadership in advancing high-quality scientific evidence and innovating for patients. These new data – spanning aortic, mitral and tricuspid therapies – provide further understanding of the complexity of structural heart disease and the need for innovative treatment options.",
                "category": "company",
                "datetime": 1782483300,
                "headline": "Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves"
              },
              {
                "id": 140712255,
                "url": "https://finnhub.io/api/news?id=a9a0f050cff8fd433fe6026943b71c8fdff53264da5ddef0fa11d04499e6f753",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Norway-based CardioMech AS, a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology in Fridley, MN, today announced the appointment of Ramin Mousavi as Chairman of the Board, effective immediately.",
                "category": "company",
                "datetime": 1782295260,
                "headline": "CardioMech Shareholders Appoint Ramin Mousavi as Chairman of the Board"
              },
              {
                "id": 140692686,
                "url": "https://finnhub.io/api/news?id=9136e702e7dfcc5d1df79a35985827ce407a733b50c7ff47e028abad22e65c19",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Globus Medical faces inflation, geopolitical and currency pressures as rising costs and FX losses cloud margin flexibility and international growth.",
                "category": "company",
                "datetime": 1782138480,
                "headline": "Here's How Macro Trends and Currency Headwind Restrict GMED's Growth"
              },
              {
                "id": 140691146,
                "url": "https://finnhub.io/api/news?id=843562ed61fee58039a285e36f019315c1d1a32065cd26057a37a4840411af50",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "EW",
                "summary": "Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.",
                "category": "company",
                "datetime": 1782131700,
                "headline": "What's going on in today's pre-market session: S&P500 movers"
              },
              {
                "id": 140649984,
                "url": "https://finnhub.io/api/news?id=4d3531c17ab01cc674c5d093405b9301938682be5e2f3d2c05b0282b3d78a4fe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.57%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.89%. June E-mini S&P futures (ESM26 ) fell -0.60%, and June E-mini Nasdaq futures...",
                "category": "company",
                "datetime": 1781642036,
                "headline": "Stocks Indexes Finish Mostly Lower as Chipmakers Retreat"
              },
              {
                "id": 140646075,
                "url": "https://finnhub.io/api/news?id=21e901af7de0ec0c8d3fab3785c00c1c5e94d83a5ea7dcac3909c404c4549df4",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "EW",
                "summary": "Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.",
                "category": "company",
                "datetime": 1781627701,
                "headline": "Exploring the top movers within the S&P500 index during today's session."
              },
              {
                "id": 140645723,
                "url": "https://finnhub.io/api/news?id=079359cd4836c6e3619ed467a2a41e63411fc713f6730aadcbd94434c4558687",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences (EW) is expected to benefit from the Centers for Medicare & Medicaid Services'",
                "category": "company",
                "datetime": 1781624993,
                "headline": "Edwards Lifesciences Seen Benefiting From CMS Transcatheter Aortic Valve Replacement Rule, RBC Says"
              },
              {
                "id": 140649043,
                "url": "https://finnhub.io/api/news?id=ed3cde22831ae1098d949d7d33b72dd9da82db5fee1fc510faa8b2594a4fd5de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "The S&P 500 Index ($SPX ) (SPY ) today is down -0.18%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.69%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.83%. June E-mini S&P futures (ESM26 ) are down -0.20%, and June E-mini Nasdaq futures...",
                "category": "company",
                "datetime": 1781622938,
                "headline": "Broader Market Weakens as Energy and Software Stocks Fall"
              },
              {
                "id": 140648875,
                "url": "https://finnhub.io/api/news?id=638b4a14e4a9725ebf97bb9f2652aa7a734159b63f87d2a7f2d27b885c9ab349",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "The S&P 500 Index ($SPX ) (SPY ) today is up +0.11%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.57%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.18%. June E-mini S&P futures (ESM26 ) are up +0.09%, and June E-mini Nasdaq futures...",
                "category": "company",
                "datetime": 1781619490,
                "headline": "Stocks Supported by Lower Crude Oil Prices and Bond Yields"
              },
              {
                "id": 140657685,
                "url": "https://finnhub.io/api/news?id=fa7001622e453f3c8a87f2cfb80ca9ccd62c8ad4efd0d5b139f0eda1c28b0a96",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/16/Irvine--California---7-May-2023-Edwards-.jpeg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "CMS proposes easing TAVR coverage rules and expanding access, a move analysts say could strengthen Edwards Lifesciences' market position.",
                "category": "company",
                "datetime": 1781617967,
                "headline": "Edwards Lifesciences Stands Out As US Agency Eyes Broader Access For Heart Valve Device"
              },
              {
                "id": 140654422,
                "url": "https://finnhub.io/api/news?id=4310716eabd489977375bda6235de8bf999adc394f0dcb834a28574bbda42de0",
                "image": "https://image.cnbcfm.com/api/v1/image/108322628-17816273621781627357-46583759523-1080pnbcnews.jpg?v=1781627361&w=1920&h=1080",
                "source": "CNBC",
                "related": "EW",
                "summary": "The Investment Committee debate how to position your portfolio near record highs as stocks look to extend the Monday snapback.",
                "category": "company",
                "datetime": 1781614266,
                "headline": "The market rally's road ahead: How to position near record highs"
              },
              {
                "id": 140644822,
                "url": "https://finnhub.io/api/news?id=b8ebd9a3b34af8095ea3d9e0bdd2ecb876408be3cd6107aefe82da74b3240ec6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Investing.com - U.S. stock futures were little changed on Tuesday, while oil prices extended recent losses, as investors awaited further details on a preliminary peace agreement between the United States and Iran.",
                "category": "company",
                "datetime": 1781613852,
                "headline": "SpaceX, Rackspace surge premarket; Edgewise Therapeutics, Huntsman fall"
              },
              {
                "id": 140644730,
                "url": "https://finnhub.io/api/news?id=856f656f82ba08e49ec9bf8abb135b4efc9a69ec0d62382256c4dd6e45725cdb",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "EW",
                "summary": "Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session.",
                "category": "company",
                "datetime": 1781613300,
                "headline": "Stay updated with the S&P500 stocks that are on the move in today's pre-market session."
              },
              {
                "id": 140647034,
                "url": "https://finnhub.io/api/news?id=3d96b5ea169e397d4b4305ec49ea961dfeead658b7d81538363b53ec5e3584b7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "The proposed Medicare coverage change could help Edwards Lifesciences gain market share from Medtronic and Boston Scientific, an analyst said.",
                "category": "company",
                "datetime": 1781607916,
                "headline": "CMS proposes Medicare coverage expansion for TAVR"
              },
              {
                "id": 140645988,
                "url": "https://finnhub.io/api/news?id=c42054ddc0086ea279f32492940ebd700e57bc00d6b6d7ebb49c91219990ae2c",
                "image": "",
                "source": "Benzinga",
                "related": "EW",
                "summary": "RBC Capital  analyst Shagun Singh   reiterates Edwards Lifesciences (NYSE:EW) with a Outperform and maintains $100 price target.",
                "category": "company",
                "datetime": 1781602507,
                "headline": "RBC Capital Reiterates Outperform on Edwards Lifesciences, Maintains $100 Price Target"
              },
              {
                "id": 140617502,
                "url": "https://finnhub.io/api/news?id=3440504532b35800b440041e745c94590c02c83e57a3e183f93b4024ede5ed35",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards gains from strong TMTT growth, RESILIA adoption and expanding TAVR use, but macro pressures and currency swings remain key risks.",
                "category": "company",
                "datetime": 1781267460,
                "headline": "Should You Continue to Hold EW Stock in Your Portfolio?"
              },
              {
                "id": 140582299,
                "url": "https://finnhub.io/api/news?id=fb6f13d08b877506eee8ba1556c9c2305e7b73adbdfdf44d203c6b6b2cbdd90b",
                "image": "https://image.cnbcfm.com/api/v1/image/108318920-17810228181781022815-46442812417-1080pnbcnews.jpg?v=1781022817&w=1920&h=1080",
                "source": "CNBC",
                "related": "EW",
                "summary": "The Investment Committee debate the latest Calls of the Day.",
                "category": "company",
                "datetime": 1781008925,
                "headline": "Calls of the Day: Health Care and Materials"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 2,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.2,
            "source_article_count": 25,
            "discarded_article_count": 23
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 21.3,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 1.6,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.6,
            "vcp_reason": "波幅收縮(14.5%→10.8%);站上MA50;Ready=N;Confirm=N",
            "vcp_metrics": {
              "up_days": 8,
              "vol_ref": 5158956.666666667,
              "down_days": 1,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 4966750,
              "avg_vol_20": 4830390,
              "avg_vol_30": 5158956.666666667,
              "range_pct_10": 0.10809955705547354,
              "range_pct_20": 0.1307740982914996,
              "range_pct_30": 0.14501160092807425,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": false,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.962743112787017,
              "dist_to_20d_high": 0.007847650936486346,
              "down_shrink_days": 1,
              "breakout_level_20d": 95.57,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.7454545454545456
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.6071503902130355,
              "turnoverUsdM": 419.1356906,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.EW",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 89.8758,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 5.2,
            "take_profit_price": 99.9867,
            "target_multiplier": 1.9,
            "technical_strength": 1.65,
            "take_profit_percent": 5.4
          },
          "positionPoints": 1.6,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.214300780426071,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 2.4721,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.61
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 152.42
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0005
    },
    "kdj": {
      "d": 82.4,
      "j": 96.13,
      "k": 86.98,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "強資金流入",
      "score": 10,
      "value": 75.48
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 59506370,
      "recentSlope": 3025847,
      "previousSlope": -94420
    },
    "rsi": 74.46,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 87.9818,
      "position": "SAR喺價下",
      "distancePct": 7.21,
      "previousTrend": "上升"
    },
    "ma50": 85.802,
    "macd": {
      "macd": 2.4480417060088797,
      "trend": "強烈看漲",
      "signal": 1.8521611210323217,
      "histogram": 0.595880584976558
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 89.07,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 10
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.93,
      "score": 4,
      "avgVolume": 4762457,
      "currentVolume": 4420330
    },
    "derived": {
      "ma20": 89.0065,
      "ma50": 85.802,
      "prevClose": 95.18,
      "avgVolume10": 5058133,
      "avgVolume20": 4762457,
      "changePercent": -0.38,
      "avgVolumeForScore": 4762457
    },
    "ma_cross": {
      "ma20": 89.0065,
      "ma50": 85.802,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 88.5635,
      "prevMa50": 85.5,
      "spreadPct": 3.73,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 82.7258,
      "upper": 95.2872,
      "position": "上半部"
    },
    "rsi_short": 82.58,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.93
    }
  }
}

Raw metrics JSON

{
  "close": 94.82,
  "volume": 4420330,
  "changePercent": -0.38
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.